OMCL — OMNICELL, INC.

Nasdaq · Information Technology · Technology Hardware, Storage & Peripherals · CIK 926326 ·
Last close
$35.37
Market Cap
$1.61B
52W High
$48.06
52W Low
$35.00
ADV30
829,864
Next earnings
2026-10-29
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2026
Mar 2026
Dec 2025 313,984,000 130,325,000 415,000 -2,026,000 1,974,720,000 196,520,000 742,906,000
Sep 2025 310,631,000 134,503,000 8,244,000 5,462,000 1,948,597,000 180,053,000 727,695,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$127,300,000
Investing CF
$-60,363,000
Financing CF
$-218,317,000
CapEx
$-57,933,000
Dividends Paid
Buybacks
$-61,948,000
EPS Diluted TTM
$0.44
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$384,940,000
Inventory
$100,905,000
Receivables
$216,858,000
ST Investments
$14,648,000
EBIT TTM
$5,160,000
Pretax Income TTM
$11,325,000
Interest Exp TTM
Analysts
7

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,246,702,976
EBITDA
$96,184,000
Free Cash Flow
$153,988,128
Enterprise Value
$1,588,896,000
Total Cash
$292,164,992
Total Debt
$188,511,008
Shares Out
45,478,909
Trailing EPS
$0.84
Book Value
$27.63
ROE
3.1%
ROA
1.9%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,184,845,000 5,160,000 2,052,000 1,974,720,000 742,906,000 127,300,000
Dec 2024 1,112,238,000 337,000 12,531,000 2,120,960,000 877,647,000 187,722,000
Dec 2023 1,147,112,000 -34,868,000 -20,371,000 2,226,878,000 1,037,924,000 181,094,000
Dec 2022 1,295,947,000 -2,323,000 5,648,000 2,210,758,000 1,080,621,000 77,781,000

TTM Snapshot

Revenues TTM
$1,225,544,000
NetIncome TTM
$60,274,000
OpCashFlow TTM
$0
Assets (Latest)
$2,120,960,000
Forward EPS
$2.17

Max Pain — expiry 2026-08-21 (volume-derived — Yahoo OI feed degraded)

max pain strike: $35.00 · spot: $35.37 · call volume: 33 · put volume: 107
Expected Move to 2026-08-21: ±$3.09 (8.74%) — implied range $32.28$38.46 · ATM straddle on $35.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
VYX NCR Voyix Corp $1.14B $8.27
CRSR Corsair Gaming, Inc. $1.13B $10.61
DBD DIEBOLD NIXDORF, Inc $2.50B $73.59
EVLV Evolv Technologies Holdings, Inc. $994.69M $5.53
MITK MITEK SYSTEMS INC $754.15M $16.70

News headlines (Yahoo Finance, 1h cache)

OMCL Q2 Earnings Call Highlights Titan XT Pipeline Growth
2026-07-31 14:00 · Yahoo
Omnicell (OMCL) Stock Trades Down, Here Is Why
2026-07-30 23:33 · Yahoo
Omnicell Inc (OMCL) (Q2 2026) Earnings Call Highlights: Strong Profitability and Strategic Wins ...
2026-07-30 21:05 · Yahoo
EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination
2026-07-30 20:01 · Yahoo
Omnicell Q2 Earnings Call Highlights
2026-07-30 18:04 · Yahoo
Omnicell (OMCL) Q2 Earnings and Revenues Top Estimates
2026-07-30 11:50 · Yahoo
Omnicell’s (NASDAQ:OMCL) Q2 CY2026: Beats On Revenue But Stock Drops On Weak Guidance
2026-07-30 11:27 · Yahoo
Omnicell Announces Second Quarter 2026 Financial Results
2026-07-30 10:30 · Yahoo
Omnicell (OMCL) Reports Q2: Everything You Need To Know Ahead Of Earnings
2026-07-29 17:49 · Yahoo
2 Cash-Heavy Stocks to Target This Week and 1 We Turn Down
2026-07-22 10:14 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.